Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients
Authors:
- Jiazhong SunJSJiazhong Sun
- Yancheng XuYXYancheng Xu
- Jinge XueJXJinge Xue
- Yilian ZhuYZYilian Zhu
- Hongyun LuHLHongyun Lu
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 229 (1-2) , 95-101
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Association Between End-Stage Diabetic Nephropathy and Methylenetetrahydrofolate Reductase Genotype with Macroangiopathy in Type 2 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2003
- Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitusClinica Chimica Acta, 2002
- Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?Diabetologia, 1998
- C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populationsAtherosclerosis, 1998
- The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous ThrombosisThrombosis and Haemostasis, 1997
- Methylenetetrahydrofolate Reductase Gene and Coronary Artery DiseaseCirculation, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitusScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatmentAtherosclerosis, 1993